Giambattista La Forgia

Cardiovascular Surgeon. MD. Ávila Clinic. Caracas. Venezuela

[AATS @AATSHQ]

Open access in #JTCVS Structural and Endovascular: Current surgical guidelines recommending #aortic repair for dilatation ≥45 mm should be strongly considered in patients undergoing TAVR evaluation. Learn more from surgeons at @UMich: https://t.co/q3Mycu347o

[Eric E. Roselli @EricRoselliMD]

Complex LVOT obstruction and aortic stenosis demand innovation.

Our novel BeSPoKE technique, developed @ClevelandClinic, enhances hemodynamics and prepares anatomy for future TAVR.

@Dr_HaniNajm @CleClinicHVTI @CCF_CTSRes #AortaEd #CLEaorta
https://t.co/tF1WjCMBaM

[JACC Journals @JACCJournals]

Ex-vivo study of 23 to 34 mm Evolut THVs: IFU-guided post-dilation preserved frame geometry and leaflet integrity. Oversized balloons caused waist over-expansion and immediate leaflet tears. https://t.co/W9Ym1erij2 #JACCINT

[Kendra J. Grubb MD, MHA, MSc @KendraGrubb]

6-year #Evolut Low Risk Trial published in #JACC - no difference in all-cause mortality or disabling stroke between TAVR and surgery.

Reintervention reflect earlier-generation Evolut R devices and pre-2020 techniques - reflective of historical rather than contemporary practice.

[Rosana Ferrero 📈📊🙌 @RosanaFerrero]

📊 ¿𝘾𝙤́𝙢𝙤 𝙚𝙡𝙚𝙜𝙞𝙧 𝙚𝙡 𝙜𝙧𝙖́𝙛𝙞𝙘𝙤 𝙖𝙙𝙚𝙘𝙪𝙖𝙙𝙤?
Y, ¿Qué tipo de gráfico clave falta en el resumen?
Te leo.

Imagen de Cédric Scherer https://t.co/rVjztHQJcc
#stats #DataViz #Analytics #DataScience #Visualization #BigData #Statistics #Storytelling #rstats #python

[大島 晋 | 大動脈外科 (Susumu Oshima | Aortic surgery) @SusumuOshima]

"Durable treatment is mandatory for aortic diseases"- Insight from Prof. Morad's visit to KAC

Today: A patient deemed "cured" after TEVAR at a university hospital.
Reality: 80mm aortic aneurysm requiring emergency open surgery.

The issue isn't the device—TEVAR is excellent for appropriate cases.

The issue is system failure: Complex cases in young patients need referral to centers capable of durable open repair BEFORE attempted endovascular "solutions."

"Can do" ≠ "Should do"

We need courage to choose the RIGHT treatment, not just the AVAILABLE treatment.

We need courage to refer patients to appropriate centers.

This is what patient-centered care truly means.

600 open TAAA cases/year taught me this lesson repeatedly.

#AorticSurgery #TEVAR #OpenRepair #DurableTreatment

[Igor Konstantinov @konstantinov_ie]

Proper understanding of geometry of aortic root is a must for durable repair.
Konstantinov IE, et al. Surgical Mathematics of Aortic Root: Toward Durable Aortic Valve Repair. J Thorac Cardiovasc Surg 2026 doi: 10.1016/j.jtcvs.2025.12.028. PMID: 41519195
https://t.co/Jc1hIwexls

[Igor Konstantinov @konstantinov_ie]

For proper understanding of surgical geometry of aortic root read:
Konstantinov IE, et al. Surgical Mathematics of Aortic Root: Toward Durable Aortic Valve Repair. J Thorac Cardiovasc Surg 2026 doi: 10.1016/j.jtcvs.2025.12.028. PMID: 41519195
https://t.co/Jc1hIwexls

[Davide Capodanno @DFCapodanno]

A 78-year-old man with undergoing transfermoral TAVI had embolization of a balloon-expandable valve into the descending aorta. Initially stable, he developed acute paraplegia the next morning due to delayed valve twisting with near-occlusive aortic flow and spinal hypoperfusion. Emergency valve-in-valve implantation restored flow, with complete neurological recovery within one week.
https://t.co/9d8wY9O04f

[Comunidad Biológica @Bio_comunidad]

Estamos viendo a un niño apenas 36 horas después de recibir un trasplante de corazón… la ciencia dándole una segunda oportunidad de vida ❤️

[Bo Yang @BoYangMD]

SAVR +Y-incision AAE outperforms TAVR in hemodynamics in low-intermediate risk patients with severe AS during 3 years f/u. see our paper in JTCVS ENDO, (Fig below: mean G and EOA; PPM.) https://t.co/W15ZsM7qKu

[Edgar Argulian @argulian]

It is fascinating that an anatomic study has confirmed what echocardiography previously suggested: tricuspid valve is not tricuspid most of the times due to leaflet scalloping, most commonly of the posterior leaflet.

https://t.co/Ed4QZqWcFC

[EHJ Editor-in-Chief @ehj_ed]

A must-read paper in #EHJ!
Coronary revascularization: a long-term perspective.
A State-of-the-Art review forecasting advancements by 2040, drawing on historical trends and recent breakthroughs.
@escardio @ESC_Journals #CardioTwitter

https://t.co/2I8oeozR6s

[Giambattista La Forgia @Giam00]

Transcatheter edge-to-edge repair versus mitral valve surgery in octogenarians: Comparative analysis of safety, durability, and survival - The Journal of Thoracic and Cardiovascular Surgery https://t.co/y6dLT6euNJ

[AATS @AATSHQ]

New in #JTCVS Structural and Endovascular: Root and arch replacements in acute type A aortic dissection suggest lower risk of open distal reintervention. Learn what researchers think about the more aggressive approaches: https://t.co/PlCYtGSHcG

[Giambattista La Forgia @Giam00]

David procedure + aortic arch replacement in patient w/ Aortic Type A Disecction (TA-E1-M1)

[Giambattista La Forgia @Giam00]

David procedure + aortic arch replacement in patient w/ Aortic Type A Disecction (TA-E1-M1)

[CTSNet @ctsnetorg]

ISMICS 2025 | Hybrid Coronary Revascularization Trial 2.0

At the ISMICS Annual Scientific Meeting 2025, Dr. John D. Puskas delivered a presentation titled “Hybrid Coronary Revascularization Trial 2.0.” Watch the full presentation on CTSNet today!

🔗https://t.co/SvKrzUGQU8

[Victor Dayan @VictorDayan1]

🧵 Cross-overs in RCTs: The Hidden Bias Game and the scam of the century (EARLY TAVR)

1/
Cross-overs—patients switching from assigned treatment to the other arm—can undermine trial integrity. But did you know they can help or hurt depending on trial design? Let’s break it down.

[AATS @AATSHQ]

The 15th most read AATS Journals article from last year is on left atrial appendage closure during #mitral repair in patients without atrial fibrillation. Read the study for free in #JTCVS: https://t.co/nLkL7W0Cth